The clinical data supports these mechanisms
Orlistat: It is approved for adult and adolescent obesity and works by blocking certain enzymes such as gastrointestinal lipases, reducing the amount of fat absorption from the food consumed, thus promoting weight loss
These reactions usually resolve within a few days to a week as your skin adapts to the new ingredient
Mounjaro and Zepbound work similarly, but they use tirzepatide (rather than semaglutide) to simulate both GLP-1 and a second hormone, GIP
The medication is administered via weekly subcutaneous self-injection, with dose titration starting at 0.25 mg weekly and increasing over sixteen to twenty weeks to the target dose of 2.4 mg weekly
It can be performed in the cervical, thoracic, and lumbar spine and may involve one or more facet joints